Current Report Filing (8-k)
September 22 2021 - 4:49PM
Edgar (US Regulatory)
0001142790
false
false
0001142790
2021-09-20
2021-09-20
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
September
20, 2021
Commission
File #: 000-53723
TAURIGA
SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
Florida
(State
or other jurisdiction of incorporation)
30-0791746
(IRS
Employer Identification Number)
4
Nancy Court, Suite 4
Wappingers
Falls, NY 12590
(Address
of principal executive office)
Tel:
(917) 796-9926
(Registrant’s
telephone number)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under
any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol
|
|
Name
of each exchange on which registered
|
Common
Stock, par value $0.00001 per share
|
|
TAUG
|
|
OTCQB
|
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
David
Wolitzky, Ph.D. notified Tauriga Sciences, Inc. (the “Company”) of his intention to resign from his position on the Board
of Directors of the Company (the “Board”), effective September 20, 2021, in order to attend to personal matters, and not
due to any disagreement with the Company regarding any matter related to the Company’s operations, policies or practices.
Mr.
Wolitzky’s service to the board has been greatly appreciated by management and the other board members of the Company. In expression
of his years of service, the Company has determined to issue him 2,500,000 shares of restricted common stock based on the closing price
of September 20, 2021 and a cash payment of $10,000. He has served on the Board since March 2013.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
Tauriga
Sciences, Inc.
|
|
|
|
Date:
September 22, 2021
|
By:
|
/s/
Seth M. Shaw
|
|
Name:
|
Seth
M. Shaw
|
|
Title:
|
Chief
Executive Officer
|
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Apr 2023 to Apr 2024